Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hilleman’s Pioneering Shigella Vaccine Set For First Trials

Apr 11 2017

• By Penelope MacRae

Infectious disease

Related Content

INTERVIEW: Hilleman CEO On $1 Rotavirus Vaccine Challenges

Oct 28 2015

Latecomer Hilleman Looks To Leverage Cholera Vaccine Advantages

Feb 06 2017

Related Companies

Merck & Co., Inc.

Immuron Ltd.

Serum Institute of India Pvt. Ltd.

GSK plc

Additional Topics

Vaccines Research & Development Clinical Trials Emerging Markets Infectious Diseases BioPharmaceutical

More from Anti-infective

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window